Psychostimulants may have ‘bridging’ role in cancer-related fatigue management

A class of medications widely prescribed to treat ADHD and narcolepsy can confer modest but consistent reductions in cancer-related fatigue, according to results of a systematic review and meta-analysis of randomized trials.The benefits of methylphenidate-type psychostimulants increased over time, with clinically meaningful improvements in energy and function emerging after about 5 weeks of